Zenas Biopharma Inc (NASDAQ:ZBIO)’s traded shares stood at 0.15 million during the last session. At the close of trading, the stock’s price was $10.03, to imply a decrease of -1.86% or -$0.19 in intraday trading. The ZBIO share’s 52-week high remains $26.25, putting it -161.71% down since that peak but still an impressive 41.87% since price per share fell to its 52-week low of $5.83. The company has a valuation of $419.60M, with an average of 0.2 million shares in intraday trading volume over the past 10 days and average of 191.61K shares over the past 3 months.
Zenas Biopharma Inc (NASDAQ:ZBIO) trade information
After registering a -1.86% downside in the last session, Zenas Biopharma Inc (ZBIO) has traded red over the past five days. The 5-day price performance for the stock is -1.18%, and 5.36% over 30 days. Short interest in Zenas Biopharma Inc (NASDAQ:ZBIO) saw shorts transact 4.91 million shares and set a 26.69 days time to cover.
The extremes give us $35 and $35 for target low and target high price respectively. As such, ZBIO has been trading -248.95% off suggested target high and -248.95% from its likely low.
ZBIO Dividends
Zenas Biopharma Inc has its next earnings report out on 2025-May-15. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Zenas Biopharma Inc (NASDAQ:ZBIO)’s Major holders
Zenas Biopharma Inc insiders hold 21.20% of total outstanding shares, with institutional holders owning 74.88% of the shares at 95.02% float percentage. In total, 74.88% institutions holds shares in the company.
We also have Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund and Fidelity Securities Fund-Fidelity Series Small Cap Opportunities Fund as the top two Mutual Funds with the largest holdings of the Zenas Biopharma Inc (ZBIO) shares. Going by data provided on Apr 30, 2025, Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund holds roughly 1.14 shares. This is just over 2.72% of the total shares, with a market valuation of $11.4 million. Data from the same date shows that the other fund manager holds a little less at 935.26, or 2.24% of the shares, all valued at about 9.38 million.
